David Allen Stamler
CIK: 0002130205
Transaction Breakdown
Open Market Buys (P)1 (100.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ATHE
ALTERITY THERAPEUTICS LTD
DirectorOfficer
Discretionary Trading P&L
Holdings
About Stamler David Allen
Stamler David Allen (SEC CIK 0002130205) files insider reports with the SEC as Chief Executive Officer of ALTERITY THERAPEUTICS LTD (ATHE).
Signal8 holds 2 ownership filings by Stamler David Allen (1 Form 3, 1 Form 4), filed between Apr 15, 2026 and Sep 8, 2026. Those filings report 1 transaction, the latest on Aug 31, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Stamler David Allen's filings is in NEWARK, CA.
Recent filings by Stamler David Allen
- Aug 31, 2026: Open-market purchase of ATHE derivative securities (Form 4, code P).
Other insiders filing for ALTERITY THERAPEUTICS LTD (ATHE)
- Marks Peter Ashley, Director
- Babarczy Julian Michael, Director
- Gozlan Lawrence Bernard, Director
- Cunningham Ann Michelle, Director
- Macnish Niven Abby Sarah, Chief Financial Officer